MIP Diagnostics Overview
- Founded
- 2015

- Status
- Private
- Employees
- 19

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $6.38M

- Investors
- 7
MIP Diagnostics General Information
Description
Developer of molecular imprinted polymers (MIPS) and nanoMIPs/plastic antibodies technology designed to circumvent the drawbacks of traditional MIP manufacturing methods. The company's polymers and antibodies typically contain a single binding site for their target and can be fused to solid substrates, such as sensor surfaces, thus providing hospitals with ideal reagents for a wide range of applications including point-of-care diagnostics and in field-based testing.
Contact Information
- The Exchange Building
- Colworth Park, Sharnbrook
- Bedford MK44 1LQ
- England, United Kingdom
MIP Diagnostics Timeline
MIP Diagnostics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Later Stage VC | 01-Jul-2020 | $6.38M | 00.00 | 0000 | Completed | Generating Revenue |
5. Early Stage VC (Series A) | 08-May-2018 | 00.000 | 00.00 | 00.000 | Completed | Generating Revenue |
4. Early Stage VC | 28-Jun-2017 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
3. Early Stage VC | 21-Oct-2016 | 00000 | 00000 | 00.000 | Completed | Startup |
2. Early Stage VC | 22-Dec-2015 | $274K | $274K | 00.000 | Completed | Startup |
1. Grant | Completed | Startup |
MIP Diagnostics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
C Ordinary | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
C Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
A Ordinary | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
B Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
B Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
A Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
A Ordinary | 3,308 | $0.012513 | $68.82 | $68.82 | 1x | $68.82 | 5.58% | |
A Ordinary | 3,000 | $0.012513 | $62.56 | $62.56 | 1x | $62.56 | 5.06% |
MIP Diagnostics Executive Team (6)
MIP Diagnostics Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
James Syrotiuk | Self | Board Member | 000 0000 |
Jim Reid | MIP Diagnostics | Chairman | 000 0000 |
Mark Payton Ph.D | Self | Board Member | 000 0000 |
Stephane Argivier | MIP Diagnostics | Chief Executive Officer and Board Member | 000 0000 |
William Brooks | Self | Board Member | 000 0000 |
MIP Diagnostics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMIP Diagnostics Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
BGF | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
Downing Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Andrew Fisher | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Calculus Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
David Evans | Angel (individual) | Minority | 000 0000 | 000000 0 |